Current treatment options in infectious diseases最新文献

筛选
英文 中文
The Present and Future State of Antimicrobial Stewardship and Rapid Diagnostic Testing: Can One Ideally Succeed Without the Other? 抗菌素管理和快速诊断测试的现状和未来:两者缺一不可吗?
Current treatment options in infectious diseases Pub Date : 2019-06-01 DOI: 10.1007/s40506-019-00190-9
K. Zeitler, Navaneeth Narayanan
{"title":"The Present and Future State of Antimicrobial Stewardship and Rapid Diagnostic Testing: Can One Ideally Succeed Without the Other?","authors":"K. Zeitler, Navaneeth Narayanan","doi":"10.1007/s40506-019-00190-9","DOIUrl":"https://doi.org/10.1007/s40506-019-00190-9","url":null,"abstract":"","PeriodicalId":72759,"journal":{"name":"Current treatment options in infectious diseases","volume":"11 1","pages":"177-187"},"PeriodicalIF":0.0,"publicationDate":"2019-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s40506-019-00190-9","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48941030","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 11
Advances in Infection Control for Clostridioides (Formerly Clostridium) difficile Infection 艰难梭菌感染控制研究进展
Current treatment options in infectious diseases Pub Date : 2019-03-01 DOI: 10.1007/s40506-019-0179-y
Carlos E Figueroa Castro, L. Munoz-Price
{"title":"Advances in Infection Control for Clostridioides (Formerly Clostridium) difficile Infection","authors":"Carlos E Figueroa Castro, L. Munoz-Price","doi":"10.1007/s40506-019-0179-y","DOIUrl":"https://doi.org/10.1007/s40506-019-0179-y","url":null,"abstract":"","PeriodicalId":72759,"journal":{"name":"Current treatment options in infectious diseases","volume":"11 1","pages":"12-22"},"PeriodicalIF":0.0,"publicationDate":"2019-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s40506-019-0179-y","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43986564","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Procalcitonin as a Diagnostic, Therapeutic, and Prognostic Tool: a Critical Review 降钙素原作为一种诊断、治疗和预后工具:综述
Current treatment options in infectious diseases Pub Date : 2019-02-21 DOI: 10.1007/s40506-019-0178-z
Fabricio Rodrigues Torres de Carvalho, Roberto Rabello Filho, Lucas Bulgarelli, A. Serpa Neto, R. Deliberato
{"title":"Procalcitonin as a Diagnostic, Therapeutic, and Prognostic Tool: a Critical Review","authors":"Fabricio Rodrigues Torres de Carvalho, Roberto Rabello Filho, Lucas Bulgarelli, A. Serpa Neto, R. Deliberato","doi":"10.1007/s40506-019-0178-z","DOIUrl":"https://doi.org/10.1007/s40506-019-0178-z","url":null,"abstract":"","PeriodicalId":72759,"journal":{"name":"Current treatment options in infectious diseases","volume":"11 1","pages":"1-11"},"PeriodicalIF":0.0,"publicationDate":"2019-02-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s40506-019-0178-z","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"52813997","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Innovations in Quality Improvement of Intravascular Catheter-Related Bloodstream Infections 血管内导管相关血流感染质量改进的创新
Current treatment options in infectious diseases Pub Date : 2019-02-08 DOI: 10.1007/s40506-019-0180-5
Rajendra Karnatak, M. Rupp, Kelly A. Cawcutt
{"title":"Innovations in Quality Improvement of Intravascular Catheter-Related Bloodstream Infections","authors":"Rajendra Karnatak, M. Rupp, Kelly A. Cawcutt","doi":"10.1007/s40506-019-0180-5","DOIUrl":"https://doi.org/10.1007/s40506-019-0180-5","url":null,"abstract":"","PeriodicalId":72759,"journal":{"name":"Current treatment options in infectious diseases","volume":"11 1","pages":"23-41"},"PeriodicalIF":0.0,"publicationDate":"2019-02-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s40506-019-0180-5","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44976584","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Treatment of Tuberculosis in Brazil—Past, Present, and Future Challenges 巴西结核病的治疗——过去、现在和未来的挑战
Current treatment options in infectious diseases Pub Date : 2019-01-26 DOI: 10.1007/s40506-019-0182-3
D. Jarovsky
{"title":"Treatment of Tuberculosis in Brazil—Past, Present, and Future Challenges","authors":"D. Jarovsky","doi":"10.1007/s40506-019-0182-3","DOIUrl":"https://doi.org/10.1007/s40506-019-0182-3","url":null,"abstract":"","PeriodicalId":72759,"journal":{"name":"Current treatment options in infectious diseases","volume":"11 1","pages":"58-72"},"PeriodicalIF":0.0,"publicationDate":"2019-01-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s40506-019-0182-3","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47767782","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Bacterial Antibiotic Resistance: on the Cusp of a Post-antibiotic World 细菌抗生素耐药性:后抗生素时代的尖端
Current treatment options in infectious diseases Pub Date : 2019-01-26 DOI: 10.1007/s40506-019-0181-4
Kameron Sprigg, C. Pietrangeli
{"title":"Bacterial Antibiotic Resistance: on the Cusp of a Post-antibiotic World","authors":"Kameron Sprigg, C. Pietrangeli","doi":"10.1007/s40506-019-0181-4","DOIUrl":"https://doi.org/10.1007/s40506-019-0181-4","url":null,"abstract":"","PeriodicalId":72759,"journal":{"name":"Current treatment options in infectious diseases","volume":"11 1","pages":"42-57"},"PeriodicalIF":0.0,"publicationDate":"2019-01-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s40506-019-0181-4","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44996363","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
Physician barriers to implementation of hospital-based antimicrobial stewardship programs (ASPs): a global perspective 医生实施医院抗菌药物管理计划的障碍:全球视角
Current treatment options in infectious diseases Pub Date : 2019-01-22 DOI: 10.1007/s40506-019-0183-2
L. Kaljee, Tyler Prentiss, M. Zervos
{"title":"Physician barriers to implementation of hospital-based antimicrobial stewardship programs (ASPs): a global perspective","authors":"L. Kaljee, Tyler Prentiss, M. Zervos","doi":"10.1007/s40506-019-0183-2","DOIUrl":"https://doi.org/10.1007/s40506-019-0183-2","url":null,"abstract":"","PeriodicalId":72759,"journal":{"name":"Current treatment options in infectious diseases","volume":"11 1","pages":"73-80"},"PeriodicalIF":0.0,"publicationDate":"2019-01-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s40506-019-0183-2","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43850269","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Update on Adverse Effects of HIV Integrase Inhibitors. 艾滋病毒整合酶抑制剂不良反应的最新情况。
Current treatment options in infectious diseases Pub Date : 2019-01-01 Epub Date: 2019-11-16 DOI: 10.1007/s40506-019-00203-7
Agnieszka Kolakowska, Anaenza Freire Maresca, Intira Jeannie Collins, Johann Cailhol
{"title":"Update on Adverse Effects of HIV Integrase Inhibitors.","authors":"Agnieszka Kolakowska, Anaenza Freire Maresca, Intira Jeannie Collins, Johann Cailhol","doi":"10.1007/s40506-019-00203-7","DOIUrl":"10.1007/s40506-019-00203-7","url":null,"abstract":"<p><strong>Purpose of review: </strong>The goal of this paper is to provide an up-to-date review of adverse events related to the class of integrase strand transfer inhibitors (INSTIs), which became the class of choice in few years. We sought answers specifically to issues pertaining to neuropsychiatric adverse events, as well as weight gain, which were the two most important categories of adverse events raised in recent studies based on real-life experience. The primary focus of this paper is on adults with a brief summary on pregnant women and children/adolescents.</p><p><strong>Recent findings: </strong>Dolutegravir (DTG) bears the heaviest burden of neuropsychiatric side effects. Weight gain was reported with all INSTIs, although there are methodological caveats in the analyses and the findings need to be interpreted with caution.Moreover, due to recent findings on neural tube defects in infants exposed to dolutegravir during their peri-conception period, its use is not recommended for women of childbearing age without proper birth control method, while raltegravir remains the only drug which may be prescribed without caution. Given the importance of cognitive and metabolic co-morbidities in people living with HIV in regard to their quality of life, future research needs to focus on long-term effects of INSTIs in relation to these adverse events. Pharmacogenetics seems to be a promising tool. Safety during pregnancy is also another important issue to further clarify.</p><p><strong>Summary: </strong>INSTIs are a generally well-tolerated class of antiretrovirals (ARV), and has a higher antiviral potency compared to other classes of ARV.Clinicians and patients need however to be aware of some red flags when starting with and monitoring patients on INSTIs.All INSTIs can lead to mild increases in creatinine levels, usually without clinical significance, but caution is needed in patients with low eGFR (<30ml/min), when using other nephrotoxic drugs, such as as tenofovir disoproxil.Neuro-psychiatric (NP) effects are to be monitored with INSTIs, especially with DTG (though reports are at times contradictory); clinicians might want to avoid DTG for patients with history of severe NP symptoms, until clarity is provided.Weight gain was reported with all INSTIs, especially with DTG, with possible differential effects according to sex and ethnicity (female and non-white patients being at increased risk). This is worrying since patients from African descent are at higher risk of cardio-vascular events and increased body mass index (BMI) can cause further increase metabolic risk. There is possibly an additional effect of tenofovir alafenamide (TAF) on weight increase.Discrepancies between clinical trials - with low rates of adverse events - and reports from real-life settings might be due partly to under-representation of some groups of patients in clinical trials, and/or the short duration of follow-up, since some adverse effects may only occur after prolo","PeriodicalId":72759,"journal":{"name":"Current treatment options in infectious diseases","volume":"11 4","pages":"372-387"},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7758219/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38767623","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Current Challenges in Antibiotic Stewardship in Low- and Middle-Income Countries 当前中低收入国家抗生素管理面临的挑战
Current treatment options in infectious diseases Pub Date : 2018-07-17 DOI: 10.1007/s40506-018-0175-7
A. Galindo-Fraga, M. Villanueva-Reza, E. Ochoa-Hein
{"title":"Current Challenges in Antibiotic Stewardship in Low- and Middle-Income Countries","authors":"A. Galindo-Fraga, M. Villanueva-Reza, E. Ochoa-Hein","doi":"10.1007/s40506-018-0175-7","DOIUrl":"https://doi.org/10.1007/s40506-018-0175-7","url":null,"abstract":"","PeriodicalId":72759,"journal":{"name":"Current treatment options in infectious diseases","volume":"10 1","pages":"421-429"},"PeriodicalIF":0.0,"publicationDate":"2018-07-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s40506-018-0175-7","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48920299","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Cutaneous Botryomycosis and Staphylococcus aureus: Diagnosis, Management, and a Systemic Literature Review 皮肤芽孢菌病和金黄色葡萄球菌:诊断、管理和系统文献综述
Current treatment options in infectious diseases Pub Date : 2018-07-16 DOI: 10.1007/s40506-018-0176-6
Pamela Bailey, Jillian E. Raybould, Sangeeta Sastry, G. Bearman
{"title":"Cutaneous Botryomycosis and Staphylococcus aureus: Diagnosis, Management, and a Systemic Literature Review","authors":"Pamela Bailey, Jillian E. Raybould, Sangeeta Sastry, G. Bearman","doi":"10.1007/s40506-018-0176-6","DOIUrl":"https://doi.org/10.1007/s40506-018-0176-6","url":null,"abstract":"","PeriodicalId":72759,"journal":{"name":"Current treatment options in infectious diseases","volume":"10 1","pages":"347-361"},"PeriodicalIF":0.0,"publicationDate":"2018-07-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s40506-018-0176-6","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44202741","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信